Sargramostim

Sargramostim
Clinical data
ATC code	L03AA09 (WHO) ;
Identifiers
	IUPAC name Human granulocyte macrophage colony stimulating factor;
CAS Number	83869-56-1;
DrugBank	BTD00035;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C639H1006N168O196S8
Molar mass	14434.5 g/mol

Sargramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as a immunostimulator.^[1]

It is produced in yeast.^[2]

References

↑ Kirman I, Belizon A, Balik E; et al. (2007). "Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery". doi:10.1016/j.ejso.2007.03.014. PMID 17512160.
↑ Beveridge RA, Miller JA, Kales AN; et al. (1998). "A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression". Cancer Invest. 16 (6): 366–73. PMID 9679526.

Clinical data
ATC code	L03AA09 (WHO)
Identifiers
IUPAC name Human granulocyte macrophage colony stimulating factor
CAS Number	83869-56-1
DrugBank	BTD00035
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₆₃₉H₁₀₀₆N₁₆₈O₁₉₆S₈
Molar mass	14434.5 g/mol